搜尋





搜尋





市場行情
/
股票
/
rlay
/

Relay Therapeutics Inc

RLAY

添加自選

18.830USD

-0.620-3.19%

收盤 07-31 16:00（美東）報價延遲15分鐘

4.06B總市值

虧損本益比TTM

Relay Therapeutics Inc

18.830

-0.620-3.19%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

RLAY 利潤表

您可以在這裡找到Relay Therapeutics Inc的年度或季度收入報告，以深入了解Relay Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業總收入

-60.93%3.00M

--7.00M

--0.00

--677.00K

-23.26%7.68M

--0.00

-100.00%0.00

4327.88%10.01M

-100.00%0.00

7226.16%25.20M

-67.40%119.00K

-46.06%226.00K

-55.38%253.00K

-48.35%344.00K

-56.75%365.00K

-55.99%419.00K

-99.31%567.00K

--666.00K

--844.00K

--952.00K

--82.65M

----

營業收入

-60.93%3.00M

--7.00M

--0.00

--677.00K

-23.26%7.68M

--0.00

----

-100.00%0.00

4327.88%10.01M

-100.00%0.00

7226.16%25.20M

-67.40%119.00K

-46.06%226.00K

-55.38%253.00K

-48.35%344.00K

-56.75%365.00K

-55.99%419.00K

-99.31%567.00K

--666.00K

--844.00K

--952.00K

--82.65M

----

營業費用

-11.84%81.59M

-20.42%67.63M

-16.58%80.39M

-30.86%77.52M

-9.45%92.55M

-9.85%84.98M

-3.61%96.37M

3.52%112.13M

-0.20%102.20M

12.69%94.26M

20.49%99.98M

38.92%108.32M

51.19%102.41M

24.01%83.65M

39.09%82.97M

30.90%77.98M

56.23%67.73M

41.51%67.45M

62.96%59.66M

114.90%59.57M

63.87%43.36M

84.52%47.67M

67.09%36.61M

39.26%27.72M

61.31%26.46M

--25.83M

--21.91M

--19.91M

--16.40M

研發費用

-4.40%70.56M

-24.91%58.18M

-10.91%68.26M

-30.54%63.90M

-10.43%73.81M

-0.02%77.48M

-5.98%76.62M

4.30%91.99M

-0.51%82.40M

15.19%77.50M

21.81%81.49M

45.76%88.20M

60.31%82.83M

31.70%67.28M

51.47%66.90M

36.34%60.51M

72.79%51.67M

62.60%51.08M

86.94%44.17M

111.86%44.38M

42.47%29.90M

40.20%31.41M

34.03%23.63M

32.53%20.95M

57.38%20.99M

--22.41M

--17.63M

--15.81M

--13.34M

折舊攤銷及損耗

-58.28%504.00K

-55.10%599.00K

-45.28%748.00K

-26.75%1.00M

-13.41%1.21M

--1.33M

0.29%1.37M

2.55%1.37M

16.54%1.40M

----

31.95%1.36M

39.54%1.33M

22.77%1.20M

12.77%1.17M

2.08%1.03M

-0.42%956.00K

6.09%975.00K

13.38%1.03M

10.84%1.01M

10.98%960.00K

6.98%919.00K

6.92%912.00K

44.01%913.00K

25.18%865.00K

28.79%859.00K

--853.00K

--634.00K

--691.00K

--667.00K

其他營業費用

----

70.61%-2.77M

----

---9.41M

----

---97.00K

----

營業利潤

7.40%-78.59M

28.65%-60.63M

16.58%-80.39M

31.47%-76.85M

7.95%-84.87M

9.85%-84.98M

-28.88%-96.37M

-3.63%-112.13M

9.77%-92.19M

-13.03%-94.26M

9.50%-74.78M

-39.42%-108.20M

-51.79%-102.18M

-24.68%-83.39M

-40.07%-82.63M

-32.16%-77.61M

-58.75%-67.32M

-291.17%-66.89M

-61.14%-58.99M

-111.86%-58.73M

-60.27%-42.41M

235.44%34.99M

-67.09%-36.61M

-39.26%-27.72M

-61.31%-26.46M

---25.83M

---21.91M

---19.91M

---16.40M

淨非營業利息收入（費用）

利息收入

-31.50%5.35M

-36.37%5.71M

-22.56%6.41M

-16.87%7.11M

-12.71%7.81M

3.15%8.97M

5.47%8.27M

13.07%8.55M

28.96%8.95M

61.95%8.70M

357.97%7.84M

652.14%7.56M

897.27%6.94M

1911.99%5.37M

991.08%1.71M

458.33%1.00M

207.96%696.00K

-9.80%267.00K

-70.60%157.00K

-81.96%180.00K

-85.62%226.00K

-84.58%296.00K

-76.12%534.00K

-57.85%998.00K

-30.96%1.57M

--1.92M

--2.24M

--2.37M

--2.28M

股權收益

----

--0.00

100.00%0.00

----

--0.00

---11.86M

----

特殊收入（費用）

----

--0.00

-100.00%0.00

----

-100.00%0.00

428.53%11.37M

82.65%1.83M

-80.41%2.07M

136.79%1.20M

1176.00%2.15M

-78.17%1.00M

1361.24%10.54M

-63.10%-3.26M

99.84%-200.00K

--4.59M

---836.00K

---2.00M

---123.00M

----

其他非經營性收入（費用）

-488.89%-53.00K

2900.00%30.00K

-1550.00%-165.00K

-31550.00%-633.00K

-136.00%-9.00K

0.00%1.00K

-400.00%-10.00K

85.71%-2.00K

933.33%25.00K

104.17%1.00K

-128.57%-2.00K

-177.78%-14.00K

85.71%-3.00K

---24.00K

--7.00K

1700.00%18.00K

-320.00%-21.00K

100.00%0.00

133.33%1.00K

---5.00K

---8.00K

-400.00%-5.00K

---3.00K

100.00%0.00

--0.00

---1.00K

--0.00

---57.00K

稅前利潤

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

8.97%-76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

-23.69%-83.50M

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.37%-84.17M

60.30%-76.79M

-47.08%-62.05M

-291.22%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

247.52%35.28M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

所得稅

----

--0.00

----

除稅後利潤

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

---76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

----

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.37%-84.17M

60.30%-76.79M

-47.08%-62.05M

-291.22%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

247.52%35.28M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

持續經營利潤

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

8.97%-76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

-23.69%-83.50M

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.37%-84.17M

60.30%-76.79M

-47.08%-62.05M

-291.22%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

247.52%35.28M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

歸屬少數股東的淨利潤

----

--0.00

----

歸属于母公司的淨利潤

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

8.97%-76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

-23.69%-83.50M

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.37%-84.17M

60.30%-76.79M

-47.08%-62.05M

52.67%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

-495.96%-142.51M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

優先股派息

----

--0.00

----

--177.79M

----

歸屬普通股東的淨利潤

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

8.97%-76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

-23.69%-83.50M

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.37%-84.17M

60.30%-76.79M

-47.08%-62.05M

52.67%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

-495.96%-142.51M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

基本每股收益

10.51%-0.41

30.24%-0.32

31.54%-0.43

40.81%-0.41

26.79%-0.46

32.21%-0.45

-16.83%-0.63

14.24%-0.69

19.92%-0.62

-20.03%-0.67

29.14%-0.54

-14.54%-0.81

-35.58%-0.78

15.07%-0.56

-15.64%-0.76

66.40%-0.71

-22.51%-0.57

58.58%-0.66

-29.61%-0.66

-583.84%-2.10

-63.26%-0.47

-415.60%-1.59

-131.41%-0.51

-57.70%-0.31

-75.48%-0.29

---0.31

---0.22

---0.20

---0.16

稀釋每股收益

10.51%-0.41

30.24%-0.32

31.54%-0.43

40.81%-0.41

26.79%-0.46

32.21%-0.45

-16.83%-0.63

14.24%-0.69

19.92%-0.62

-20.03%-0.67

29.14%-0.54

-14.54%-0.81

-35.58%-0.78

15.07%-0.56

-15.64%-0.76

66.40%-0.71

-22.51%-0.57

58.58%-0.66

-29.61%-0.66

-583.84%-2.10

-63.26%-0.47

-415.60%-1.59

-131.41%-0.51

-57.70%-0.31

-75.48%-0.29

---0.31

---0.22

---0.20

---0.16

每股派息

--0.00

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Relay Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 RLAY 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Relay Therapeutics Inc 財年末的營收是多少？



Relay Therapeutics Inc 2025 財年營收為 15.36M，高於上一財年的 10.01M。

Relay Therapeutics Inc 最近一個季度的營收是多少？



Relay Therapeutics Inc 最近一個季度的營收為 3.00M，同比增長 -60.93%。

Relay Therapeutics Inc 全年的淨利潤是多少？



Relay Therapeutics Inc 2025 財年淨利潤為 -276.48M。

Relay Therapeutics Inc 上一季度的淨利潤是多少？



Relay Therapeutics Inc 最近一個季度的淨利潤為 -73.29M。

Relay Therapeutics Inc 年度營業利潤是多少？



Relay Therapeutics Inc 2025 財年的營業利潤為 -302.74M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。